Company news

Share this article:
MANUFACTURER NEWS
Astellas Pharma Technologies is offering early retirement to 200 workers at its Norman, OK, plant. The cuts anticipate the patent expiration Flomax.
 
Merck KGaA, the German manufacturer of Erbitux cancer treatment, has announced a partnership with Belgian biotech Ablynx NV to develop tumor and immune disorder treatments. 
 
 
AGENCY NEWS
Concentric Pharma Advertising has won an AOR assignment on Surfaxin, an investigational respiratory distress syndrome (RDS) treatment manufactured by Discovery Labs.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.